Source

Commission Implementing Regulation (EU) 2026/2348 of 23 October 2026 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 2,5-dichlorobenzoic acid methylester, acequinocyl, acetic acid, aluminium phosphide, amidosulfuron, buprofezin, calcium carbide, emamectin, ethylene, fatty acids C7 to C20, fenoxaprop-P, flonicamid (IKI-220), halosulfuron-methyl, iron sulphate, magnesium phosphide, metamitron, orange oil, quinmerac, sodium silver thiosulfate, sulcotrione, tembotrione, Trichoderma asperellum strains ICC012, T25 and TV1, Trichoderma atroviride strain T-11, Trichoderma gamsii strain ICC080, Trichoderma harzianum strains T-22 and ITEM 908, and zinc phosphide

Implementing Regulation (EU) 2026/2348 · Regulation · 3 articles

In forceIn force from 2026-10-23

Version historyWe hold this version only; in force from 2026-10-23.

Data as of 2026-11-01 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Open ↗

The Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.

Article 2

Open ↗

This Regulation shall enter into force on the third day following that of its publication in the Official Journal of the European Union .

Supplementary provisions

ANNEXSupplementary provisions

Open ↗

ANNEX 1. Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows: (1) in the sixth column, expiration of approval, of row 169, Amidosulfuron, the date is replaced by ‘31 August 2027’; (2) in the sixth column, expiration of approval, of row 182, Fenoxaprop-P, the date is replaced by ‘31 August 2027’; (3) in the sixth column, expiration of approval, of row 204, Trichoderma atroviride (formerly T. harzianum ) strain T-11, the date is replaced by ‘31 January 2028’; (4) in the sixth column, expiration of approval, of row 206, Trichoderma harzianum Rifai strains T-22 and ITEM 908, the date is replaced by ‘31 January 2028’; (5) in the sixth column, expiration of approval, of row 207, Trichoderma asperellum (formerly T. harzianum ) strains ICC012, T25 and TV1, the date is replaced by ‘31 January 2028’; (6) in the sixth column, expiration of approval, of row 208, Trichoderma gamsii (formerly T. viride ) strain ICC080, the date is replaced by ‘31 January 2028’; (7) in the sixth column, expiration of approval, of row 218, Acetic acid, the date is replaced by ‘15 November 2028’; (8) in the sixth column, expiration of approval, of row 223, Calcium carbide, the date is replaced by ‘31 January 2028’; (9) in the sixth column, expiration of approval, of row 227, Ethylene, the date is replaced by ‘31 May 2029’; (10) in the sixth column, expiration of approval, of row 230, Fatty acids C7 to C20, the date is replaced by ‘31 January 2028’; (11) in the sixth column, expiration of approval, of row 235, Iron sulphate, the date is replaced by ‘31 May 2030’; (12) in the sixth column, expiration of approval, of row 260, Aluminium phosphide, the date is replaced by ‘31 January 2029’; (13) in the sixth column, expiration of approval, of row 262, Magnesium phosphide, the date is replaced by ‘31 January 2029’; (14) in the sixth column, expiration of approval, of row 265, 2,5-Dichlorobenzoic acid methylester, the date is replaced by ‘15 May 2028’; (15) in the sixth column, expiration of approval, of row 266, Metamitron, the date is replaced by ‘31 July 2029’; (16) in the sixth column, expiration of approval, of row 267, Sulcotrione, the date is replaced by ‘15 August 2028’; (17) in the sixth column, expiration of approval, of row 305, Flonicamid (IKI-220), the date is replaced by ‘15 October 2029’; (18) in the sixth column, expiration of approval, of row 311, Quinmerac, the date is replaced by ‘31 May 2029’; (19) in the sixth column, expiration of approval, of row 314, Zinc phosphide, the date is replaced by ‘31 May 2030’; (20) in the sixth column, expiration of approval, of row 320, Buprofezin, the date is replaced by ‘15 March 2027’. 2. Part B of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows: (1) in the sixth column, expiration of approval, of row 35, Halosulfuron-methyl, the date is replaced by ‘15 August 2027’; (2) in the sixth column, expiration of approval, of row 49, Emamectin, the date is replaced by ‘15 May 2029’; (3) in the sixth column, expiration of approval, of row 56, Orange oil, the date is replaced by ‘30 November 2029’; (4) in the sixth column, expiration of approval, of row 59, Tembotrione, the date is replaced by ‘31 May 2029’; (5) in the sixth column, expiration of approval, of row 63, Sodium silver thiosulfate, the date is replaced by ‘30 November 2029’; (6) in the sixth column, expiration of approval, of row 72, Acequinocyl, the date is replaced by ‘15 January 2029’.

Other acts of the same type

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

What to look at next

Browse all EU Legal ActsEvery instrument by type and year, full text free to read section by sectionEuropean Union legislation EU Legal Acts by type and yearGrouped by instrument type and year of enactment, so you can find others of the same kindBrowse by type and year European Union: what this database coversWhich datasets are here, which official source they come from, and how current they areEuropean Union overview